New 3-Drug cocktail targets Hard-to-Treat leukemia
Disease control
Recruiting now
This early-phase study tests whether adding ruxolitinib to two standard drugs (azacitidine and venetoclax) is safe and tolerable for people with acute myeloid leukemia (AML) that has returned or not responded to prior treatment. About 51 adults will receive the combination to fin…
Phase: PHASE1 • Sponsor: Jennifer Saultz • Aim: Disease control
Last updated May 04, 2026 16:22 UTC